U.S. Dialysis Services Market Analysis

U.S. Dialysis Services Market Analysis

To get key market trends

  Download Free Sample

Based on type, the market is segmented into hemodialysis and peritoneal dialysis. The hemodialysis segment dominated the market in 2023 with a revenue of USD 29.3 billion.

• The increasing instances of chronic kidney disorders and end-stage renal disease have heightened the burden of renal disorders. According to a recent report from the Centers for Disease Control and Prevention (CDC), around 15% of adults in the U.S. are suffering from chronic kidney disease (CKD), and over 360 patients prepare to undergo dialysis for kidney failure every 24 hours.

   

• Hemodialysis is the most commonly used modality for dialysis treatment in the U.S. It involves filtering blood through an artificial kidney (dialyzer) to remove waste products and excess fluid. The widespread adoption of hemodialysis is attributed to its effectiveness in managing end-stage renal disease (ESRD) and its availability in various healthcare settings, including dialysis centers, hospitals, and even home-based settings.

   

• Additionally, the U.S. healthcare system has a well-established infrastructure to support hemodialysis services. Dialysis centers equipped with hemodialysis equipment, trained staff, and medical resources are widely accessible across the country. This infrastructure facilitates the delivery of hemodialysis treatments to a large patient population, contributing to its dominant market share.

   

Based on service, the U.S. dialysis services market is classified into acute dialysis and chronic dialysis. The chronic dialysis segment held a substantial market revenue of USD 27.1 billion in 2023.

• Patients with ESRD typically require long-term or lifelong dialysis treatment to manage their condition effectively. Chronic dialysis involves regular, scheduled sessions, usually multiple times per week, to remove waste products and excess fluids from the bloodstream. This ongoing treatment regimen ensures that patients receive the necessary renal support to maintain their health and well-being.

   

• Furthermore, chronic dialysis services are delivered in specialized healthcare settings staffed by multidisciplinary teams of nephrologists, nurses, technicians, and other healthcare professionals with expertise in renal care. These teams provide comprehensive clinical management, monitoring, and supportive care to patients undergoing chronic dialysis, ensuring optimal treatment outcomes and patient well-being, and contributing to the widespread adoption of these services.

Based on end-use, the U.S. dialysis services market is segmented into in-center dialysis and home dialysis. The in-center dialysis segment dominated the market in 2023 and is anticipated to reach USD 38.6 billion by 2032.

• Dialysis centers are equipped with advanced dialysis machines and medical professionals specializing in renal care. This access to specialized equipment and staff enhances the quality of care provided to patients, leading to better treatment outcomes and providing reassurance for patients and their families.

   

• Furthermore, in-center dialysis facilities offer a structured and controlled environment for patients during their treatment sessions. The clinical setting provides a sense of security and familiarity for patients, allowing them to feel comfortable and relaxed during their dialysis treatments.

   

• In-center dialysis is typically covered by insurance plans, including Medicare and private insurance. This coverage makes it an accessible option for many patients, eliminating financial barriers to treatment and increasing its preference among individuals with end-stage renal disease (ESRD).

   

• As a result, the in-center segment is poised to maintain its high market share in the market, driving continued innovation and adoption of dialysis services.

The South Atlantic zone held a dominant position in the U.S. dialysis services market, with a revenue of USD 7.7 billion in 2023.

• The high market share in the South Atlantic zone can be attributed to several factors, including the presence of key market players, a robust research and development infrastructure, significant government funding for dialysis research, and a high adoption rate of advanced technologies in the healthcare sector.

   

• Additionally, high healthcare expenditure and insurance coverage contribute to the accessibility and affordability of dialysis services and treatments for patients in the South Atlantic zone.

   

North East zone exhibits a high growth potential in the U.S. dialysis services market.

• North East zone is a leading market for dialysis services in the U.S., with a strong healthcare system and high standards of care.

   

• The increasing demand for dialysis in several states of the North East zone can be attributed to factors such as improved awareness, the need for effective disease management, the convenience of home dialysis, aging population, government support, and technological advancements.

   

• Additionally, the increasing prevalence of ESRD and the growing demand for personalized medicine in North East region contribute to the expansion of dialysis services.

   

The Mountain States dialysis services market is expected to exhibit the fastest growth over the forecast period.

• Contributing factors include the growing incidence of diabetes, hypertension, obesity, and aging populations. These conditions gradually impair kidney function over time, leading to CKD.

   

• Moreover, efforts to promote kidney health in the region are improving access to screening and early detection, thereby mitigating the burden of renal disorders on individuals and society and significantly contributing to market growth.